Article Abstract

Professor Hope S. Rugo: Reversing resistance and hormone therapy for metastatic breast cancer

Authors: Molly J. Wang


Hope S. Rugo, MD (Figure 1) is a Professor of Medicine in the Division of Hematology and Oncology at the Helen Diller Family Comprehensive Cancer Center of the University of California, San Francisco (UCSF), where she directs Breast Cancer and Clinical Trial Education Breast Oncology and Clinical Trails Education. Her research interests include novel therapies for advanced breast cancer, immune modulation to restore chemotherapy sensitivity evaluation of circulating cells as novel markers of response and resistance to therapy, neoadjuvant therapy, and supportive care.